SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014323
Filing Date
2024-04-11
Accepted
2024-04-11 16:07:29
Documents
25
Period of Report
2024-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55710
2 ex4-1.htm EX-4.1 119612
3 ex4-2.htm EX-4.2 119742
4 ex5-1.htm EX-5.1 32701
5 ex5-2.htm EX-5.2 20613
6 ex10-1.htm EX-10.1 250048
7 ex99-1.htm EX-99.1 16185
8 ex99-2.htm EX-99.2 14002
9 ex5-1_001.jpg GRAPHIC 7884
10 ex5-2_001.jpg GRAPHIC 11475
11 ex5-2_002.jpg GRAPHIC 3974
12 ex5-2_003.jpg GRAPHIC 1999
13 ex5-1_002.jpg GRAPHIC 7444
  Complete submission text file 0001493152-24-014323.txt   975440

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE vbiv-20240409.xsd EX-101.SCH 3024
15 XBRL LABEL FILE vbiv-20240409_lab.xml EX-101.LAB 34240
16 XBRL PRESENTATION FILE vbiv-20240409_pre.xml EX-101.PRE 22365
29 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3488
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 24838570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)